Latest Breaking News On - Immunic inc - Page 7 : comparemela.com

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanRobertj foxJessica breuAlexandra herrmannPaula schwartzDaniel vittMellen centerAmericas committee for treatmentResearch in multiple sclerosisNeurological instituteImmunic incExchange commissionDistribution servicesRx communications groupPresents data from phase

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesWest palm beachStephen gunnionDaniel vittAmericas committee for treatmentResearch in multiple sclerosisImmunic incAmericas committeeMultiple sclerosisEpstein barr virus

Immunic to present data for lead asset vidofludimus calcium from Phase 2 MS and COVID-19 trials

Immunic Inc (NASDAQ:IMUX) announced that it will present data from its Phase 2 CALLIPER and CALVID-1 clinical trials of its lead asset vidofludimus calcium.

West palm beachUnited statesDaniel vittImmunic incResearch in multiple sclerosisAmericas committee for treatmentAmericas committeeMultiple sclerosis

Immunic And 2 Other Stocks Under $2 Insiders Are Buying - Fresh Tracks Therapeutics (OTC:FRTX), Immunic (NASDAQ:IMUX)

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Daniel vittHealth incExploration capitalImmunic incFrost gamma investmentsDow jonesFresh tracks therapeutics incFrost gamma investments trustImmunic doesBest buy andFresh tracks therapeuticsFresh tracks therapeutics does

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesAlexandra herrmannDaniel vittPaula schwartzEdna kaplanRobertj foxJessica breuNeurological instituteImmunic incAmericas committee for treatmentExchange commissionMellen centerResearch in multiple sclerosisPresents data from phaseVidofludimus calciumAmericas committee